Potential of PAQosome as a therapeutic target for hepatic fibrosis.

Shi, Liu; Feng, Gong; Yang, Xueliang; Zhang, Yang; Zhang, Yu; Cheng, Jun; Lin, Shumei

Shi, Liu; Feng, Gong; Yang, Xueliang; Zhang, Yang; Zhang, Yu; Cheng, Jun; Lin, Shumei.

Afiliación

Shi L; Department of Infectious Disease Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Feng G; Department of Infectious Disease Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yang X; Xi'an Medical University, Xi'an, China.
Zhang Y; Department of Rehabilitation Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang Y; Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Cheng J; Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Lin S; Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

J Gastroenterol Hepatol ; 39(2): 381-391, 2024 Feb.

Article en En | MEDLINE | ID: mdl-38016755

Asunto(s)

Aspartatoamoníaco Ligasa; Humanos; Aspartatoamoníaco Ligasa/metabolismo; Fosfatidilinositol 3-Quinasas/metabolismo; Cirrosis Hepática/genética; Cirrosis Hepática/metabolismo; FN-kappa B/metabolismo; Fibrosis; Factor de Crecimiento Transformador beta1/metabolismo; Células Estrelladas Hepáticas/metabolismo; Proteínas de Ciclo Celular/metabolismo; Chaperonas Moleculares/metabolismo

Palabras clave

ASDURF; ASNSD1; Hepatic fibrosis; PAQosome; Signaling pathway

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Aspartatoamoníaco Ligasa Límite: Humans Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google